Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
Stock Information for Lantern Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.